Status:
NOT_YET_RECRUITING
Volume-Restricted Resection for Perihilar Cholangiocarcinoma
Lead Sponsor:
Yongjun Chen
Conditions:
Cholangiocarcinoma, Hilar
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to learn about the safety and long-term outcomes of volume-restricted liver resection in patients with perihilar cholangiocarcinoma (pCCA) who have an insuffici...
Detailed Description
Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising at the confluence of the right and left hepatic bile ducts. Its deep anatomical location and proximity to critical vascular stru...
Eligibility Criteria
Inclusion
- Patients with pathologically confirmed hilar cholangiocarcinoma, or those with a high index of clinical suspicion for hilar bile duct malignancy despite the lack of histological confirmation.
- Patients who are able to understand and cooperate with this study.
- Patients who are able to provide and sign the written informed consent form before undergoing any screening procedures related to the study.
Exclusion
- Patients with preoperatively or intraoperatively confirmed distant metastasis, including peritoneal dissemination, distant lymph node metastasis, hepatic or other organ metastasis.
- Patients who underwent palliative surgery only.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2034
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07149558
Start Date
January 1 2026
End Date
January 1 2034
Last Update
September 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.